Year All News202420232022202120202019201820172016 Mar 10 2021 Achilles Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2021 Read More + Mar 1 2021 Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States Read More + Feb 5 2021 Achilles Therapeutics Announces Additional Financing Plans Read More + Feb 5 2021 Achilles Therapeutics Announces Independent Data and Safety Monitoring Committee Review with a Positive Recommendation to Continue with Current Study Design of the Phase I/IIa CHIRON and THETIS Trials Read More + Feb 4 2021 Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager Read More + Jan 7 2021 Achilles Therapeutics to present at the 39th Annual J.P. Morgan Healthcare Conference Read More + Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3
Mar 10 2021 Achilles Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2021 Read More +
Mar 1 2021 Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States Read More +
Feb 5 2021 Achilles Therapeutics Announces Independent Data and Safety Monitoring Committee Review with a Positive Recommendation to Continue with Current Study Design of the Phase I/IIa CHIRON and THETIS Trials Read More +
Feb 4 2021 Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager Read More +
Jan 7 2021 Achilles Therapeutics to present at the 39th Annual J.P. Morgan Healthcare Conference Read More +
